|
Model Number NX1000-3-A |
Device Problem
Adverse Event Without Identified Device or Use Problem (2993)
|
Patient Problems
Headache (1880); High Blood Pressure/ Hypertension (1908); Renal Failure (2041)
|
Event Date 10/13/2021 |
Event Type
Injury
|
Manufacturer Narrative
|
The involved device was not received for evaluation.
A review of the device history record (dhr) was conducted which confirmed that the product met all quality criteria and manufacturing specifications prior to release.
Factors outside the scope of nxstage therapy can impact the patient''s electrolytes, these include but are not limited to dietary and supplemental intake and the patient's comorbidities.
The user guide (ug) warns "appropriate monitoring of the patient¿s hemodynamic, fluid, electrolyte, and acid-base balance should be performed regularly, per physician orders, to ensure appropriate response to therapy".
(b)(4).
|
|
Event Description
|
A report was received on 16 oct 2021 from the home therapy nurse (htn) of a (b)(6)-year-old male patient with a medical history including multiple comorbidities and end stage renal disease, who stated that the patient experienced headache and hypertension (systolic in 220s mmhg) and required hospitalization following hemodialysis treatment on (b)(6) 2021.
Additional information was received on 22 oct 2021 from the htn stating that the patient was admitted to hospital (b)(6) 2021 with a diagnosis of uncontrolled hypertension, headache, acute on chronic renal failure and hyperkalemia (7.
1 mmol/l).
Hospitalization included pharmacologic intervention (sodium bicarbonate, calcium gluconate, insulin and glucose) and dialysis therapy with stabilization of the patient¿s laboratory values and vital signs.
Over the counter supplements containing potassium were discontinued and the patient recovered without sequelae.
The patient was discharged on (b)(6) 2021 to continue hemodialysis therapy using the nxstage system.
|
|
Search Alerts/Recalls
|
|
|